Is Inflammatory Bowel Disease a Risk Factor for Early Atherosclerosis?

被引:67
作者
Dagli, Necati [1 ]
Poyrazoglu, Orhan K. [3 ]
Dagli, A. Ferda [4 ]
Sahbaz, Fatih [2 ]
Karaca, Ilgin [1 ]
Kobat, M. Ali [1 ]
Bahcecioglu, Ibrahim H. [3 ]
机构
[1] Firat Univ, Dept Cardiol, TR-23100 Elazig, Turkey
[2] Firat Univ, Dept Internal Med, TR-23100 Elazig, Turkey
[3] Firat Univ, Dept Gastroenterol, TR-23100 Elazig, Turkey
[4] Firat Univ, Dept Pathol, TR-23100 Elazig, Turkey
关键词
atherosclerosis; homocysteine; inflammation; inflammatory bowel disease; intima media thickness; insulin resistance; INTIMA-MEDIA THICKNESS; ACCELERATED ATHEROSCLEROSIS; INSULIN-RESISTANCE; HYPERHOMOCYSTEINEMIA; PATHOGENESIS; SENSITIVITY; COAGULATION; STIFFNESS; GLUCOSE;
D O I
10.1177/0003319709333869
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives: Chronic inflammatory diseases are associated with an accelerated atherosclerotic process. Recent studies have discussed whether inflammatory bowel diseases (IBDs) can predict early atherosclerosis. We investigated this possibility. Methods: The study consisted of IBD cases (group 1, n = 40) and healthy persons (group 2, n = 40). The IBD group was selected so as not to have vascular disease or the presence of established major cardiovascular risk factors. Results: Group 1 cases showed a significant increase in carotid intima media thickness (cIMT; P = .01). Carotid artery stiffness was impaired in group 1 (P = .03) and high-sensitivity C-reactive protein (hsCRP), homeostasis model assessment of insulin resistance (HOMA-IR), and homocysteine (Hyc) were higher in group 1 patients (P = .02, P = .03, P = .05). Conclusions: Inflammatory bowel disease patients have an increased risk of early atherosclerosis as shown by greater values of cIMT, carotid artery stiffness, Hyc, hsCRP, and insulin resistance.
引用
收藏
页码:198 / 204
页数:7
相关论文
共 38 条
[1]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[2]   Increased insulin resistance and β cell activity in patients with Crohn's disease [J].
Bregenzer, N ;
Hartmann, A ;
Strauch, U ;
Schölmerich, J ;
Andus, T ;
Bollheimer, LC .
INFLAMMATORY BOWEL DISEASES, 2006, 12 (01) :53-56
[3]  
Capristo E, 1999, ALIMENT PHARM THERAP, V13, P209
[4]   Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease [J].
Danese, S ;
Sgambato, A ;
Papa, A ;
Scaldaferri, F ;
Pola, R ;
Sans, M ;
Lovecchio, M ;
Gasbarrini, G ;
Cittadini, A ;
Gasbarrini, A .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (04) :886-895
[5]   Inflammation and coagulation in inflammatory bowel disease: The clot thickens [J].
Danese, Silvio ;
Papa, Alfredo ;
Saibeni, Simone ;
Repici, Alessandro ;
Malesci, Alberto ;
Vecchi, Maurizio .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (01) :174-186
[6]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[7]   Accelerated atherosclerosis in patients with systemic autoimmune diseases [J].
De Leeuw, K ;
Kallenberg, C ;
Bijl, M .
AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 :362-371
[8]  
Enas E A, 1996, Indian Heart J, V48, P343
[9]  
Frayn Keith N., 1993, Current Opinion in Lipidology, V4, P197, DOI 10.1097/00041433-199306000-00004
[10]  
Gazi IF, 2007, CLIN EXP RHEUMATOL, V25, P102